Technological advancements in cfDNA to refine transplant rejection risk | Natera

New Natera data being presented

The Interface of Solid Organ Transplant and Oncology: A New Paradigm with Cell-Free DNA
Monday, September 14 at 7PM-8PM PT

Kenar D Jhaveri, MD
Associate Chief, Division of Kidney Diseases and Hypertension, Northwell Health.

Michael L. Volk, MD, MSc, AGAF, FAASLD
Robert and Gladys Mitchell Professor of Medicine, Loma Linda University Health.

Angel Rodriguez, MD
Medical Director of Oncology, Natera, Inc.

Impact of Background cfDNA in Renal Transplantation and Implications in COVID-19 Cases
Tuesday, September 15 at 7PM-8PM PT

Sanjeev Akkina, MD
Associate Professor of Transplant Nephrology, Loyola University Medical Center.

Suphamai Bunnapradist MD, MS
Professor of Medicine, Renal Transplant Research, UCLA Medical Center.

Abdul A. Abdellatif, MD, FASN
Assistant Professor of Medicine Baylor College of Medicine.

Register Now

Contact Us

If you have any questions, reach out to us at